Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Polymeric Micelles + Fruquintinib in Advanced Gastric Cancer
NCT06706895Phase 2Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, fruquintinib in gastric cancer (GC), sponsored by Zhongshan Hospital, Fudan University. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
Paclitaxel Micelles for Injectionfruquintinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT06706895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06706895.